{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T17:10:15Z","timestamp":1792084215084,"version":"4.4.0"},"reference-count":78,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2_suppl_2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurology"],"published-print":{"date-parts":[[1998,8]]},"DOI":"10.1212\/wnl.51.2_suppl_2.s2","type":"journal-article","created":{"date-parts":[[2012,5,13]],"date-time":"2012-05-13T09:35:37Z","timestamp":1336901737000},"source":"Crossref","is-referenced-by-count":428,"title":["Biochemical aspects of Parkinson's disease"],"prefix":"10.1212","volume":"51","author":[{"given":"Oleh","family":"Hornykiewicz","sequence":"first","affiliation":[{"name":"From the Institute of Biochemical Pharmacology, University of Vienna, Austria."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"e_1_3_2_2_2","first-page":"2","volume":"8","year":"1952","unstructured":"Weber G. Zum Cholinesterasegehalt des Gehirns bei Hirntumoren und bei Parkinsonismus. Bull Schweiz Akad Med Wiss 1952;8:263-268.","journal-title":"Bull Schweiz Akad Med Wiss"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.1967.00470250005001"},{"key":"e_1_3_2_4_2","first-page":"1","volume":"38","year":"1960","unstructured":"Ehringer H, Hornykiewicz O. Verteilung von Noradrenalin und Dopamin (3-Hydroxytyramin) im Gehirn des Menschen und ihr Verhalten bei Erkrankungen des extrapyramidalen Systems. Klin Wochenschr 1960;38:1236-1239.","journal-title":"Klin Wochenschr"},{"key":"e_1_3_2_5_2","unstructured":"Hornykiewicz O. From dopamine to Parkinson's disease: a personal research record. In: Samson F Adelman G eds. The neurosciences: paths of discovery II. Boston: Birkh\u00e4user 1992:125-146."},{"key":"e_1_3_2_6_2","unstructured":"Hornykiewicz O. Levodopa in the 1960s: starting point Vienna. In: Poewe W Lees AJ eds. 20 Years of madopar-new avenues. Basel: Editiones Roche 1994:11-27."},{"key":"e_1_3_2_7_2","first-page":"7","volume":"43","year":"1965","unstructured":"Bernheimer H, Hornykiewicz O. Herabgesetzte Konzentration der Homovanillins\u00e4ure im Gehirn von Parkinson-kranken Menschen als Ausdruck der St\u00f6rung des zentralen Dopaminstoffwechsels. Klin Wochenschr 1965;43:711-715.","journal-title":"Klin Wochenschr"},{"key":"e_1_3_2_8_2","first-page":"4","volume":"195","year":"1975","unstructured":"Lloyd KG, Davidson L, Hornykiewicz O. The neurochemistry of Parkinson's disease: effect of L-dopa therapy. J Pharmacol Exp Ther 1975;195:453-464.","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.870100102"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(83)90261-3"},{"key":"e_1_3_2_11_2","first-page":"7","volume":"47","year":"1996","unstructured":"Wilson JM, Levey AI, Rajput A, et al. Differential changes in neurochemical markers of striatal dopamine nerve terminals in idiopathic Parkinson's disease. Neurology 1996;47:718-726.","journal-title":"Neurology"},{"key":"e_1_3_2_12_2","first-page":"4","volume":"20","year":"1973","unstructured":"Bernheimer H, Birkmayer W, Hornykiewicz O, Jellinger K, Seitelberger F. Brain dopamine and the syndromes of Parkinson and Huntington. J Neurol Sci 1973;20:415-455.","journal-title":"J Neurol Sci"},{"key":"e_1_3_2_13_2","first-page":"4","volume":"14","year":"1971","unstructured":"Fahn S, Libsch LR, Cutler RW. Monoamines in the human neostriatum: topographic distribution in normals and in Parkinson's disease and their role in akinesia, rigidity, chorea, and tremor. J Neurol Sci 1971;14:427-455.","journal-title":"J Neurol Sci"},{"key":"e_1_3_2_14_2","first-page":"8","volume":"318","year":"1988","unstructured":"Kish SJ, Shannak K, Hornykiewicz P. Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson's disease. Pathophysiologic and clinical implications. N Engl J Med 1988;318:876-880.","journal-title":"N Engl J Med"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02834129"},{"key":"e_1_3_2_16_2","first-page":"3","volume":"48","year":"1938","unstructured":"Hassler R. Zur Pathologie der Paralysis agitans und des postenzephalitischen Parkinsonismus. J Psychol Neurol 1938;48:387-476.","journal-title":"J Psychol Neurol"},{"key":"e_1_3_2_17_2","first-page":"3","volume":"54","year":"1991","unstructured":"Gibb WRG, Lees AJ. Anatomy, pigmentation, ventral and dorsal subpopulations of the substantia nigra, and differential cell death in Parkinson's disease. J Neurol Neurosurg Psychiatry 1991;54:388-396.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"e_1_3_2_18_2","unstructured":"Hornykiewicz O Pifl Ch Kish SJ Shannak K Schingnitz G. Biochemical changes in idiopathic Parkinson's disease aging and MPTP parkinsonism: similarities and differences. In: Calne DB Comi G Grippa D Horowski R Trabucchi eds. Parkinsonism and aging. New York: Raven Press 1989:57-67. [Aging series vol. 32.]"},{"key":"e_1_3_2_19_2","doi-asserted-by":"crossref","unstructured":"Hornykiewicz O Kish SJ Rajput AH. Neurochemical aspects of Parkinson's disease and the dementing brain disorders: relation to brain ageing. In: Nagatsu T Fisher A Yoshida M eds. Basic clinical and therapeutic aspects of Alzheimer's and Parkinson's diseases. Vol. 1. New York: Plenum Press 1990:445-452.","DOI":"10.1007\/978-1-4684-5844-2_89"},{"key":"e_1_3_2_20_2","first-page":"2","volume":"53","year":"1984","unstructured":"Crutcher MD, DeLong MR. Single cell studies of the primate putamen. I. Functional organization. Exp Brain Res 1984;53:233-243.","journal-title":"Exp Brain Res"},{"key":"e_1_3_2_21_2","first-page":"2","volume":"53","year":"1984","unstructured":"Crutcher MD, DeLong MR. Single cell studies of the primate putamen. II. Relations to direction of movement and pattern of muscular activity. Exp Brain Res 1984;53:244-258.","journal-title":"Exp Brain Res"},{"key":"e_1_3_2_22_2","first-page":"1","volume":"60","year":"1993","unstructured":"Hornykiewicz O. Parkinson's disease and the adaptive capacity of the nigrostriatal dopamine system: possible neurochemical mechanisms. Adv Neurol 1993;60:140-147.","journal-title":"Adv Neurol"},{"key":"e_1_3_2_23_2","first-page":"5","volume":"273","year":"1978","unstructured":"Lee T, Seeman P, Rajput A, Farley IJ, Hornykiewicz O. Receptor basis for dopaminergic supersensitivity in Parkinson's disease. Nature 1978;273:59-61.","journal-title":"Nature"},{"key":"e_1_3_2_24_2","first-page":"7","volume":"73","year":"1961","unstructured":"Birkmayer W, Hornykiewicz O. Der L-3,4-Dioxyphenylalanin(= L-DOPA)-Effekt bei der Parkinson-Akinesie. Wien Klin Wochenschr 1961;73:787-788.","journal-title":"Wien Klin Wochenschr"},{"key":"e_1_3_2_25_2","unstructured":"Barbeau J Sourkes TL Murphy GF. Les cat\u00e9cholamines dans la maladie de Parkinson. In: de Ajuriaguerra J ed. Monoamines et syst\u00e8me nerveux central. Gen\u00e8ve: George & Cie 1962:247-262."},{"key":"e_1_3_2_26_2","first-page":"3","volume":"276","year":"1967","unstructured":"Cotzias GC, Van Woert MH, Schiffer LM. Aromatic amino acids and modification of parkinsonism. N Engl J Med 1967;276:374-379.","journal-title":"N Engl J Med"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-4159.1983.tb12645.x"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410200103"},{"key":"e_1_3_2_29_2","first-page":"2","volume":"13","year":"1990","unstructured":"Smith AD, Bolam JP. The neural network of the basal ganglia as revealed by the study of synaptic connections of identified neurones. Trends Neurosci 1990;13:259-265.","journal-title":"Trends Neurosci"},{"key":"e_1_3_2_30_2","first-page":"3","volume":"639","year":"1994","unstructured":"Shannak K, Rajput A, Rozdilsky B, Kish S, Gilbert J, Hornykiewicz O. Noradrenaline, dopamine and serotonin levels and metabolism in the human hypothalamus: observations in Parkinson's disease and normal subjects. Brain Res 1994;639:33-41.","journal-title":"Brain Res"},{"key":"e_1_3_2_31_2","doi-asserted-by":"crossref","unstructured":"Hornykiewicz O Shannak K. Brain monoamines in progressive supranuclear palsy-comparison with idiopathic Parkinson's disease. J Neural Transm 1994;42(Suppl):219-227.","DOI":"10.1007\/978-3-7091-6641-3_17"},{"key":"e_1_3_2_32_2","first-page":"3","volume":"75","year":"1963","unstructured":"Hornykiewicz O. Die topische Lokalisation und das Verhalten von Noradrenalin und Dopamin (3-Hydroxytyramin) in der Substantia nigra des normalen und Parkinson-kranken Menschen. Wien Klin Wochenschr 1963;75:309-312.","journal-title":"Wien Klin Wochenschr"},{"key":"e_1_3_2_33_2","first-page":"4","volume":"262","year":"1987","unstructured":"Richfield EK, Young AB, Penney JB. Comparative distribution of dopamine D-1 and D-2 receptors in the basal ganglia of turtles, pigeons, rats, cats, and monkeys. J Comp Neurol 1987;262:446-463.","journal-title":"J Comp Neurol"},{"key":"e_1_3_2_34_2","first-page":"2","volume":"381","year":"1996","unstructured":"Mrzljak L, Bergson C, Pappy M, Huff R, Levenson R, Goldman-Rakic PS. Localization of dopamine D4 receptors in GABAergic neurons of the primate brain. Nature 1996;381:245-248.","journal-title":"Nature"},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.1097\/00001756-199406020-00001"},{"key":"e_1_3_2_36_2","first-page":"7","volume":"65","year":"1995","unstructured":"Yung KK, Bolam JP, Smith AD, Hersch SM, Ciliax BJ, Levey Al. Immunocytochemical localization of D1 and D2 dopamine receptors in the basal ganglia of the rat: light and electron microscopy. Neuroscience 1995;65:709-730.","journal-title":"Neuroscience"},{"key":"e_1_3_2_37_2","first-page":"2","volume":"310","year":"1984","unstructured":"Bergstrom DA, Walters JR. Dopamine attenuates the effects of GABA on single unit activity in the globus pallidus. Brain Res 1984;310:23-33.","journal-title":"Brain Res"},{"key":"e_1_3_2_38_2","first-page":"7","volume":"6","year":"1996","unstructured":"Wichmann T, Delong MR. Functional and pathophysiological models of the basal ganglia. Curr Opin Neurobiol 1996;6:751-758.","journal-title":"Curr Opin Neurobiol"},{"key":"e_1_3_2_39_2","first-page":"8","volume":"22","year":"1996","unstructured":"Ernst AM, Smelik PG. Site of action of dopamine and apomorphine on compulsive gnawing behaviour in rats. Experientia 1996;22:837.","journal-title":"Experientia"},{"key":"e_1_3_2_40_2","first-page":"4","volume":"138","year":"1987","unstructured":"Fletcher GH, Starr MS. Behavioural evidence for the functionality of D-2 but not D-1 dopamine receptors at multiple brain sites in the 6-hydroxy-dopamine-lesioned receptors at multiple brain sites in the 6-hydroxy-dopamine-lesioned rat. Eur J Pharmacol 1987;138:407-411.","journal-title":"Eur J Pharmacol"},{"key":"e_1_3_2_41_2","first-page":"3","volume":"182","year":"1990","unstructured":"Koshikawa N, Koshikawa F, Tomiyama K, Kikkuchi de Bet\u0155n K, Kamimura F, Kobayashi M. Effects of dopamine D1 and D2 agonists and antagonists injected into the nucleus accumbens and globus pallidus on jaw movements of rats. Eur J Pharmacol 1990;182:375-380.","journal-title":"Eur J Pharmacol"},{"key":"e_1_3_2_42_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.35.1.1"},{"key":"e_1_3_2_43_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.ne.01.030178.000245"},{"key":"e_1_3_2_44_2","first-page":"2","volume":"19","year":"1978","unstructured":"Price KS, Farley IJ, Hornykiewicz O, Neurochemistry of Parkinson's disease: relation between striatal and limbic dopamine. Adv Biochem Psychopharmacol 1978;19:293-300.","journal-title":"Adv Biochem Psychopharmacol"},{"key":"e_1_3_2_45_2","first-page":"6","volume":"14","year":"1980","unstructured":"Mogenson GJ, Jones DL, Yim CY. From motivation to action: functional interface between the limbic system and the motor system. Prog Neurobiol 1980;14:69-97.","journal-title":"Prog Neurobiol"},{"key":"e_1_3_2_46_2","first-page":"1","volume":"347","year":"1990","unstructured":"Sokoloff P. Giros B, Martres M-P, Bouthenet M-L, Schwartz J-C. Molecular cloning and characterization of a novel dopamine receptor (D3) as a target neuroleptics. Nature 1990;347:146-151.","journal-title":"Nature"},{"key":"e_1_3_2_47_2","first-page":"8","volume":"41","year":"1991","unstructured":"Heimer L, Zahm DS, Churchill L, Kalivas PW, Wohltmann C. Specificity in the projection patterns of accumbal core and shell in the rat. Neuroscience 1991;41:89-125.","journal-title":"Neuroscience"},{"key":"e_1_3_2_48_2","first-page":"5","volume":"18","year":"1985","unstructured":"Kish SJ, Chang LJ, Mirchandani L, Shannak K, Hornykiewicz O. Progressive supranuclear palsy: relationship between extrapyramidal disturbances, dementia, and brain neurotransmitter markers. Ann Neurol 1985;18:530-536.","journal-title":"Ann Neurol"},{"key":"e_1_3_2_49_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.40.1.1"},{"key":"e_1_3_2_50_2","first-page":"4","volume":"17","year":"1985","unstructured":"Kish SJ, Gilbert JJ, Chang LJ, Mirchandani L, Shannak K, Hornykiewicz O. Brain neurotransmitter abnormalities in neuronal intranuclear inclusion body disorder. Ann Neurol 1985;17:405-407.","journal-title":"Ann Neurol"},{"key":"e_1_3_2_51_2","first-page":"6","volume":"24","year":"1988","unstructured":"Gilbert JJ, Kish SJ, Chang LJ, Morito C, Shannak K, Hornykiewicz O. Dementia, parkinsonism, and motor neuron disease: neurochemical and neuropathological correlates. Ann Neurol 1988;24:688-691.","journal-title":"Ann Neurol"},{"key":"e_1_3_2_52_2","first-page":"6","volume":"47","year":"1971","unstructured":"Brun A, Gottfries CG, Roos BE. Studies of the monoamine metabolism in the central nervous system in Jakob-Creutzfeldt disease. Acta Neurol Scand 1971;47:642-645.","journal-title":"Acta Neurol Scand"},{"key":"e_1_3_2_53_2","first-page":"6","volume":"83","year":"1988","unstructured":"Kanazawa I, Kwak S, Sasaki H, et al. Studies on neurotransmitter markers of the basal ganglia in Pick's disease, with special reference to dopamine reduction. J Neurol Sci 1988;83:63-74.","journal-title":"J Neurol Sci"},{"key":"e_1_3_2_54_2","first-page":"3","volume":"68","year":"1987","unstructured":"Br\u00fccke T, Sofic E, Killian W, Rett A, Riederer P. Reduced concentration and increased metabolism of biogenic amines in a single case of Rett syndrome: a postmortem brain study. J Neural Transm 1987;68:315-324.","journal-title":"J Neural Transm"},{"key":"e_1_3_2_55_2","first-page":"2","volume":"35","year":"1985","unstructured":"Jankovic J, Kirpatrick JB, Blomquist KA, Langlais PJ, Bird ED. Late-onset Hallervorden-Spatz disease presenting as familial parkinsonism. Neurology 1985;35:227-234.","journal-title":"Neurology"},{"key":"e_1_3_2_56_2","first-page":"6","volume":"10","year":"1995","unstructured":"Narabayashi H. The neural mechanisms and progressive nature of symptoms of Parkinson's disease-based on clinical, neurophysiological and morphological studies. J Neural Transm [P-D Sect] 1995;10:63-75.","journal-title":"J Neural Transm [P-D Sect]"},{"key":"e_1_3_2_57_2","first-page":"4","volume":"41","year":"1963","unstructured":"Bernheimer H, Birkmayer W, Hornykiewicz O. Zur Biochemie des Parkinson-Syndroms des Menschen. Einfluss der Monoaminoxydase-Hemmer-Therapie auf die Konzentration des Dopamins, Noradrenalins und 5-Hydroxytryptamins im Gehirn. Klin Wochenschr 1963;41:465-469.","journal-title":"Klin Wochenschr"},{"key":"e_1_3_2_58_2","unstructured":"Farley IJ Hornykiewicz O. Noradrenaline in subcortical brain regions of patients with Parkinson's disease and control subjects. In: Birkmayer W Hornykiewicz O eds. Advances in parkinsonism. Basel: Roche 1976;178-185."},{"key":"e_1_3_2_59_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01498791"},{"key":"e_1_3_2_60_2","doi-asserted-by":"publisher","DOI":"10.1016\/0166-2236(85)90003-7"},{"key":"e_1_3_2_61_2","first-page":"3","volume":"66","year":"1995","unstructured":"Nisbet AP, Foster OJF, Kingsbury A, et al. Preproenkephalin and preprotachykinin messenger RNA expression in normal human basal ganglia and in Parkinson's disease. Neuroscience 1995;66:361-376.","journal-title":"Neuroscience"},{"key":"e_1_3_2_62_2","unstructured":"Lloyd KG. Neurotransmitter interactions related to central dopamine neurons. In: Youdim MBH Lovenberg W Sharman DF Lagnado JR eds. Essays in neurochemistry and neuropharmacology. Chichester: John Wiley 1977:131-207."},{"key":"e_1_3_2_63_2","first-page":"1","volume":"45","year":"1986","unstructured":"Hornykiewicz O, Kish SJ. Biochemical pathophysiology of Parkinson's disease. Adv Neurol 1986;45:19-34.","journal-title":"Adv Neurol"},{"key":"e_1_3_2_64_2","first-page":"5","volume":"2","year":"1955","unstructured":"von Buttlar-Brentano K. Das Parkinsonsyndrom im Lichte der lebensgeschichtlichen Ver\u00e4nderungen des Nucleus basalis. J Hirnforsch 1955;2:55-77.","journal-title":"J Hirnforsch"},{"key":"e_1_3_2_65_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410270103"},{"key":"e_1_3_2_66_2","first-page":"4","volume":"80","year":"1983","unstructured":"Burns RS, Chiueh CC, Markey SP, Ebert MH, Jacobowitz DM, Kopin IJ. A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methy-4-phenyl-1,2,3,5-tetrahydropyridine. Proc Natl Acad Sci USA 1983;80:4546-4550.","journal-title":"Proc Natl Acad Sci USA"},{"key":"e_1_3_2_67_2","first-page":"5","volume":"44","year":"1991","unstructured":"Pifl Ch, Schingnitz G, Hornykiewicz O. Effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine on the regional distribution of brain monoamines in the rhesus monkey. Neuroscience 1991;44:591-605.","journal-title":"Neuroscience"},{"key":"e_1_3_2_68_2","unstructured":"Hornykiewicz O Pifl Ch. The validity of the MPTP primate model for the neurochemical pathology of idiopathic Parkinson's disease. In: Briley M Marien M eds. Noradrenergic mechanisms in Parkinson's disease. Boca Raton FL: CRC Press 1994:11-23."},{"key":"e_1_3_2_69_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198107023050101"},{"key":"e_1_3_2_70_2","doi-asserted-by":"publisher","DOI":"10.1016\/0306-4522(91)90169-O"},{"key":"e_1_3_2_71_2","first-page":"3","volume":"83","year":"1992","unstructured":"Lach B, Grimes D, Benoit B, Minkiewicz-Janda A. Caudate nucleus pathology in Parkinson's disease: ultrastructural and biochemical findings in biopsy material. Acta Neuropathol (Berl) 1992;83:352-360.","journal-title":"Acta Neuropathol (Berl)"},{"key":"e_1_3_2_72_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410350704"},{"key":"e_1_3_2_73_2","first-page":"4","volume":"362","year":"1995","unstructured":"Haber SN, Ryoo H, Cox C, Lu W. Subsets of midbrain dopaminergic neurons in monkeys are distinguished by different levels of mRNA for the dopamine transporter: comparison with the mRNA for the Da receptor, tyrosine hydroxylase and calbindin immunoreactivity. J Comp Neurol 1995;362:400-410.","journal-title":"J Comp Neurol"},{"key":"e_1_3_2_74_2","first-page":"2","volume":"82","year":"1985","unstructured":"Javitch JA, D'Amato RJ, Strittmatter SM, Snyder SH. Parkinsonism-inducing neurotoxin. N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: uptake of the metabolite N-methyl-4-phenylpyridine by dopamine neurons explains selective toxicity. Proc Natl Acad Sci USA 1985;82:2173-2177.","journal-title":"Proc Natl Acad Sci USA"},{"key":"e_1_3_2_75_2","first-page":"4","volume":"16","year":"1996","unstructured":"Nirenberg MJ, Vaughan RA, Uhl GR, Kuhar MJ, Pickel VM. The dopamine transporter is localized to dendritic and axonal plasma membranes of nigrostriatal dopaminergic neurons. J Neurosci 1996;16:436-447.","journal-title":"J Neurosci"},{"key":"e_1_3_2_76_2","first-page":"7","volume":"12","year":"1997","unstructured":"Le Couteur DG, Leighton PW, McCann SJ, Pond SM. Association of a polymorphism in the dopamine-transporter gene with Parkinson's disease. Mov Disord 1997;12:760-763.","journal-title":"Mov Disord"},{"key":"e_1_3_2_77_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(94)91044-8"},{"key":"e_1_3_2_78_2","first-page":"1","volume":"69","year":"1996","unstructured":"Schapira AHV. Neurotoxicity and the mechanisms of cell death in Parkinson's disease. Adv Neurol 1996;69:161-165.","journal-title":"Adv Neurol"},{"key":"e_1_3_2_79_2","unstructured":"Rajut AH Fenton ME Sitte H Pifl C Hornykiewicz O. Brain dopamine (DA) metabolism in dyskinesia and wearing off in idiopathic Parkinson's disease [Abstract]. Neurology 1998;50(Suppl 4):A392-A393."}],"container-title":["Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.neurology.org\/doi\/pdfdirect\/10.1212\/WNL.51.2_Suppl_2.S2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,28]],"date-time":"2024-03-28T13:20:22Z","timestamp":1711632022000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.neurology.org\/doi\/10.1212\/WNL.51.2_Suppl_2.S2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,8]]},"references-count":78,"journal-issue":{"issue":"2_suppl_2","published-print":{"date-parts":[[1998,8]]}},"alternative-id":["10.1212\/WNL.51.2_Suppl_2.S2"],"URL":"https:\/\/doi.org\/10.1212\/wnl.51.2_suppl_2.s2","relation":{},"ISSN":["0028-3878","1526-632X"],"issn-type":[{"value":"0028-3878","type":"print"},{"value":"1526-632X","type":"electronic"}],"subject":[],"published":{"date-parts":[[1998,8]]}}}